Application of Structured Statistical Analyses to Identify a Biomarker Predictive of Enhanced Tralokinumab Efficacy in Phase III Clinical Trials for Severe, Uncontrolled Asthma

BMC Pulmonary Medicine - United Kingdom
doi 10.1186/s12890-019-0889-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Dupilumab Efficacy and Safety in Moderate-To-Severe Uncontrolled AsthmaEfficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

Pediatrics
Child HealthPediatricsPerinatology
2018English

Benralizumab Efficacy for Patients With Fixed Airflow Obstruction and Severe, Uncontrolled Eosinophilic Asthma

Annals of Allergy, Asthma and Immunology
Respiratory MedicinePulmonaryAllergyImmunology
2020English

A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients With Moderate to Severe Atopic Dermatitis

SKIN The Journal of Cutaneous Medicine
2018English

Bayesian Network Meta-Analysis to Assess the Comparative Efficacy and Safety of Treatments for Severe or Uncontrolled Asthma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Phase II Cancer Clinical Trials for Biomarker-Guided Treatments

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2017English

Impact of Safety Monitoring on Error Probabilities of Binary Efficacy Outcome Analyses in Large Phase III Group Sequential Trials

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2012English

Efficacy of Progesterone for Moderate to Severe Traumatic Brain Injury: A Meta-Analysis of Randomized Clinical Trials

Scientific Reports
Multidisciplinary
2015English

P68 Asthma Symptom Improvements With Benralizumab Are Associated With Improvements in Activity Functions and Quality of Life for Patients With Severe, Uncontrolled Asthma: Results of Pooled Phase Iii Benralizumab Studies

2017English

Significance Level and the Number of Trials in Confirmatory Clinical Trials in Relation to “Statistical Principles for Clinical Trials”

Japanese Journal of Biometrics
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy